Status: Recruiting
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer
This research study is being done to help determine the safety and efficacy of gadolinium based nanoparticle, Activation and Guidance of Irradiation X (AGuIX), used in conjunction with MR-guided stereotactic body radiation therapy (SBRT) in the treatment of pancreatic cancer and lung tumors.
Participants needed: 100
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Dana-Farber Cancer InstituteUpdated: May 14, 2026Locations: 2
Eligibility criteria
Participants must have measurable disease, defined as a lesion that can be accur... [+15]
Participants who have had prior radiation therapy to the chest or abdomen that w... [+17]